In a cohort of 821 patients with systemic lupus erythematosus (SLE), Demir et al. demonstrated LA positivity as the highest risk marker for thrombosis, regardless of additional aPL positivity other than anti-β2GPI IgA [35]. This evidence concerns the gene FASLG and systemic lupus erythematosus.